AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Deferred Income Tax
The difference between tax expense recognized and tax actually paid in cash during the period.
AdaptHealth Corp.NASDAQ: AHCO
Deferred Income Tax · Q1 FY2026 · quarter ended Apr 2026
Deferred income tax growth accelerates
Q1 FY2026 deferred income tax of $5.6M (cash outflow) rose 621.6% year over year, ahead of the +57.5% change in trailing-twelve-month deferred income tax. Sequentially, it rose 139900.0% from the prior quarter. Over 3 fiscal years it compounded at +37.8% a year.
Context
- Deferred income tax amounted to 1.5% of revenue in FY2025, up 0.5 pp from a year earlier.
- Deferred income tax increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +621.6% holds above the trailing-twelve-month pace of +57.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Deferred Income Tax history
USD · from the cash flow
- Latest · FY2025
- 47.16M USD
- Year-over-year change
- +47.2%
- 4-year CAGR
- +20.5%
| Period | Period end | Deferred Income Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.16M | +47.2% |
| FY2024 | 2024-12-31 | 32.05M | +151.2% |
| FY2023 | 2023-12-31 | (62.6M) | -447.1% |
| FY2022 | 2022-12-31 | 18.04M | -19.4% |
| FY2021 | 2021-12-31 | 22.38M | — |
Deferred Income Tax vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 deferred income tax of $42.34M is the largest of the 9 companies compared; the peer median is $1.3M.
- Its year-over-year change of +57.5% is the 3rd highest of 5, against a peer median of +90.1%.
- Deferred income tax amounts to 1.5% of revenue for AHCO, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $42.34M | +57.5% | +37.8% | 1.5% | |
| LTM Jun 2026 | $11.16M | — | — | 1.2% | |
| LTM Mar 2026 | $5.27M | — | — | 0.5% | |
| LTM Mar 2026 | $3.11M | +181.0% | +21.2% | 1.1% | |
| LTM Mar 2026 | $2.61M | -0.7% | +423.5% | 1.8% | |
| LTM Mar 2026 | $1.6M | +224.8% | — | 0.5% | |
| LTM Mar 2026 | $310K | -49.2% | -14.1% | 0.4% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AHCO) | $1.3M | +90.1% | +21.2% | 0.5% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 158.15M | 73.13M | (678.9M) | 94.78M | (66.04M) |
| Depreciation & Amortization | 258.05M | 351.18M | 420.59M | 365.33M | 381.93M |
| Deferred Income Tax | 22.38M | 18.04M | (62.6M) | 32.05M | 47.16M |
| Stock-Based Compensation | 25.32M | 22.4M | 22.47M | 14.88M | 21.88M |
| Change in Working Capital | (153.31M) | (108M) | (25.11M) | (26.06M) | 66.58M |
| Accounts Receivables | (29.69M) | (209K) | (28.86M) | (26.22M) | 30.99M |
| Inventory | (14.92M) | (6.3M) | 15.53M | (28.07M) | (11.49M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (108.7M) | (101.49M) | (11.78M) | 28.22M | 47.08M |
| Other Non-Cash Items | (34.92M) | 17.12M | 804.2M | 60.86M | 150.26M |
| Operating Cash Flow | 275.68M | 373.87M | 480.67M | 541.84M | 601.77M |
| Capital Expenditures | (203.31M) | (391.42M) | (337.46M) | (306.06M) | (382.39M) |
| Acquisitions (Net) | (1.62B) | (19.02M) | (19.69M) | (9.54M) | (42.38M) |
| Purchases of Investments | (1.13M) | (731K) | (128K) | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 5.32M | 121.58M |
| Investing Cash Flow | (1.82B) | (411.17M) | (357.28M) | (310.28M) | (303.19M) |
| Debt Repayment | 1.4B | (36.18M) | (51.77M) | (179.87M) | (268.48M) |
| Common Stock Issued | 278.85M | 0 | 0 | 0 | 1.21M |
| Common Stock Repurchased | 0 | (13.99M) | (29.28M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (75.68M) | (15.88M) | (11.48M) | (19.08M) | (34.93M) |
| Financing Cash Flow | 1.6B | (66.05M) | (92.53M) | (198.95M) | (302.19M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 49.67M | (103.36M) | 30.86M | 32.62M | (3.61M) |
| Free Cash Flow | 72.37M | (17.56M) | 143.2M | 235.78M | 219.38M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.